BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15356779)

  • 21. Short versus long course of antibiotics for catheter-associated urinary tract infections in patients with spinal cord injury: a randomized controlled noninferiority trial.
    Darouiche RO; Al Mohajer M; Siddiq DM; Minard CG
    Arch Phys Med Rehabil; 2014 Feb; 95(2):290-6. PubMed ID: 24035770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of StatLock securing device on symptomatic catheter-related urinary tract infection: a prospective, randomized, multicenter clinical trial.
    Darouiche RO; Goetz L; Kaldis T; Cerra-Stewart C; AlSharif A; Priebe M
    Am J Infect Control; 2006 Nov; 34(9):555-60. PubMed ID: 17097449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The etiology of urinary tract infection: traditional and emerging pathogens.
    Ronald A
    Dis Mon; 2003 Feb; 49(2):71-82. PubMed ID: 12601338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
    Stein GE
    Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.
    Christiaens TC; De Meyere M; Verschraegen G; Peersman W; Heytens S; De Maeseneer JM
    Br J Gen Pract; 2002 Sep; 52(482):729-34. PubMed ID: 12236276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of urinary tract infection in pediatric liver transplantation candidates.
    Baskin E; Ozçay F; Sakalli H; Agras PI; Karakayali H; Canan O; Haberal M
    Pediatr Transplant; 2007 Jun; 11(4):402-7. PubMed ID: 17493220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.
    Hull R; Rudy D; Donovan W; Svanborg C; Wieser I; Stewart C; Darouiche R
    J Urol; 2000 Mar; 163(3):872-7. PubMed ID: 10687996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder.
    Darouiche RO; Green BG; Donovan WH; Chen D; Schwartz M; Merritt J; Mendez M; Hull RA
    Urology; 2011 Aug; 78(2):341-6. PubMed ID: 21683991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
    J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urinary tract infections characterization in a spinal cord injury rehabilitation unit].
    Andrade MJ; Trêpa A; Castro A; Gonçalves S
    Acta Med Port; 2009; 22(3):215-22. PubMed ID: 19686621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial.
    De Ridder DJ; Everaert K; Fernández LG; Valero JV; Durán AB; Abrisqueta ML; Ventura MG; Sotillo AR
    Eur Urol; 2005 Dec; 48(6):991-5. PubMed ID: 16137822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria.
    Pedersen SS; Hørbov S; Biering-Sørensen F; Høiby N
    Paraplegia; 1990 Jan; 28(1):41-7. PubMed ID: 2152392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of urinary tract infection following spinal cord injury.
    Waites KB; Canupp KC; DeVivo MJ
    Paraplegia; 1993 Oct; 31(10):645-52. PubMed ID: 8259327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    Gesser RM; McCarroll K; Teppler H; Woods GL
    J Antimicrob Chemother; 2003 May; 51(5):1253-60. PubMed ID: 12697633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.